Focused on the research and development and production of resin materials and resin end products - Hebei Lijiang
-
AboutHebei Lijiang Biotechnology Co., Ltd. is a new material manufacturer specializing in the production of functional special ion exchange resins and disposable blood perfusion devices. It is a modern high-tech enterprise integrating the research and development, production, sales, and service of resin materials and resin end products. The company was established in April 2014 with a registered capital of 52 million yuan. It plans to cover an area of 267 acres and is located in the High-tech Industrial Park of Weixian County, Hebei Province—New Material Demonstration Park. The total investment is 510 million yuan. It is a council member unit of the Ion Exchange Resin Branch of the China Membrane Industry Association.
-
Product
-
BlogsThe company will focus on the high-end market, with the purpose of serving society, solidly carrying out technological innovation and product promotion, continuously improving the development and expansion of ion exchange resin products in emerging application fields, thereby promoting the upgrading and development of related industries.
-
Company AlbumThe current phase of construction has been fully completed and put into operation, featuring a comprehensive workshop with 42 production lines for functional ion exchange resins with an annual output of 16,800 tons and a production capacity of 30,000 tons, a wastewater treatment plant with an annual treatment capacity of 403,000 tons, and a workshop producing 5,000 tons of medical-grade magnesium sulfate annually. Trial production began in July 2016, with official production starting in January 2017.
Lijiang Biotech debuts at the 16th CPhI World Pharmaceutical Ingredients China Exhibition!
Release Time:
2016-06-28
From June 21 to 23, 2016, the 16th CPHI China World Pharmaceutical Ingredients China Exhibition was grandly held at the Shanghai New International Expo Center. Since its introduction to China in 2001, the CPhI China Exhibition has rapidly grown within a few years, leveraging favorable market development opportunities, high-quality domestic and international enterprise resources, and rich exhibition effects, becoming one of the largest pharmaceutical ingredient industry trade platforms in Asia. In 2013, it was selected by the Ministry of Commerce as a guided and supported exhibition.
As a high-standard international exhibition among similar events in Asia, the World Pharmaceutical Ingredients China Exhibition attracted more than 2,500 enterprises from over 20 countries and regions worldwide. Hebei Lijiang Biotechnology Co., Ltd. also participated in this grand event, bringing various macroporous adsorption resins highly favored in the fields of traditional Chinese and Western medicine extraction. Lijiang's macroporous adsorption resins (AB-8, D101, HPD5000, HPD417, LD-1, LD-2, etc.) are widely used in the extraction of various natural products such as ginkgo and flavonoids, as well as antibiotics like cephalosporins.
At this exhibition, our company showcased its strong scientific research capabilities to professional customers from various countries, offering customized special resins tailored to meet customers' specific needs. This laid a foundation for accelerating economic and trade exchanges with Central and Eastern European countries, expanding in-depth cooperation between our company and pharmaceutical enterprises in Eastern Europe, and injecting vigorous vitality into our company's international trade cooperation.
Keyword:
Recommended Reading
24-05-14 14:37:56
